DOV
69
-2
ZION
64
3
AZO
38
-8
HRB
35
2
MAC
62
2
CL
56
2
AMT
36
-2
DUK
47
-3
ROP
41
-7
JPM
60
-9
TAP
29
-8
DOW
40
2
BA
38
-2
WU
41
2
HRL
36
-2
DG
72
4
DRI
48
-5
SNA
48
-5
MDLZ
36
-2
EXPE
81
-2
DOV
69
-2
ZION
64
3
AZO
38
-8
HRB
35
2
MAC
62
2
CL
56
2
AMT
36
-2
DUK
47
-3
ROP
41
-7
JPM
60
-9
TAP
29
-8
DOW
40
2
BA
38
-2
WU
41
2
HRL
36
-2
DG
72
4
DRI
48
-5
SNA
48
-5
MDLZ
36
-2
EXPE
81
-2
Financhill
Back

The Glimpse Group, Inc. Vs. Kymera Therapeutics, Inc. Industry Stock Comparison

Sell
30

VRAR
The Glimpse Group, Inc.

Last Price:
$1.15
Seasonality Move:
54.6%
Buy
87

KYMR
Kymera Therapeutics, Inc.

Last Price:
$89.98
Seasonality Move:
7.7%
Sell
30
The Glimpse Group, Inc. (VRAR) is a Sell

Is The Glimpse Group, Inc. a Buy, Sell or Hold?

  • The current The Glimpse Group, Inc. [VRAR] share price is $1.11. The Score for VRAR is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
  • VRAR is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
87
Kymera Therapeutics, Inc. (KYMR) is a Buy

Is Kymera Therapeutics, Inc. a Buy, Sell or Hold?

  • The current Kymera Therapeutics, Inc. [KYMR] share price is $86.88. The Score for KYMR is 87, which is 74% above its historic median score of 50, and infers lower risk than normal.
  • KYMR is currently trading in the 80-90% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.

VRAR Stock Price Chart

What is The Glimpse Group, Inc.'s stock price today?

  • The The Glimpse Group, Inc. share price today is $1.11
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and VRAR is experiencing buying pressure, which is a positive indicator for future bullish movement.

KYMR Stock Price Chart

What is Kymera Therapeutics, Inc.'s stock price today?

  • The Kymera Therapeutics, Inc. share price today is $86.88
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and KYMR is experiencing slight selling pressure.

VRAR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.19 Buy
Relative Strength Index (14 RSI): 43.36 Sell
Chaikin Money Flow: 68099 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (1.04 - 1.32) Sell
Bollinger Bands (100): (1.24 - 1.62) Sell

KYMR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 4.97 Buy
Relative Strength Index (14 RSI): 72.81 Buy
Chaikin Money Flow: -897315 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (58.72 - 73.96) Buy
Bollinger Bands (100): (43.27 - 64.19) Buy

VRAR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 1.1 Buy
20-day SMA: 1.14 Sell
50-day SMA: 1.38 Sell
200-day SMA: 1.37 Sell
8-day EMA: 1.08 Buy
20-day EMA: 0.96 Buy
50-day EMA: 0.62 Buy
200-day EMA: 0.21 Buy

KYMR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 72.38 Buy
20-day SMA: 67.89 Buy
50-day SMA: 62.54 Buy
200-day SMA: 44.51 Buy
8-day EMA: 75.59 Buy
20-day EMA: 69.41 Buy
50-day EMA: 62.91 Buy
200-day EMA: 49.79 Buy

The Glimpse Group, Inc. Earnings Growth & VRAR Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Kymera Therapeutics, Inc. Earnings Growth & KYMR Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.18 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.63 per share, and a decrease next year of $0.36 per share.

The Glimpse Group, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Kymera Therapeutics, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):